Karl E Minges1, Jeph Herrin2,3, Paul N Fiorilli4, Jeptha P Curtis1,2. 1. Center for Outcomes Research and Evaluation, Yale School of Medicine, Yale-New Haven Hospital, New Haven, Connecticut. 2. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 3. Health Research & Educational Trust, Chicago, Illinois. 4. Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
OBJECTIVES: To develop a risk model that can be used to identify PCI patients at higher risk of readmission who may benefit from additional resources at the time of discharge. BACKGROUND: A high proportion of patients undergoing PCI are readmitted within 30 days of discharge. METHODS: The sample comprised patients aged ≥65 years who underwent PCI at a CathPCI Registry®-participating hospital and could be linked with 100% Medicare fee-for-service claims between 01/2007 and 12/2009. The sample (n = 388,078) was randomly divided into risk score development (n = 193,899) and validation (n = 194,179) cohorts. We did not count as readmissions those associated with staged revascularization procedures. Multivariable logistic regression models using stepwise selection models were estimated to identify variables independently associated with all-cause 30-day readmission. RESULTS: The mean 30-day readmission rates for the development (11.36%) and validation (11.35%) cohorts were similar. In total, 19 variables were significantly associated with risk of 30-day readmission (P < 0.05), and model c-statistics were similar in the development (0.67) and validation (0.66) cohorts. The simple risk score based on 14 variables identified patients at high and low risk of readmission. Patients with a score of ≥13 (15.4% of sample) had more than an 18.5% risk of readmission, while patients with a score ≤6 (41.9% of sample) had less than an 8% risk of readmission. CONCLUSION: Among PCI patients, risk of readmission can be estimated using clinical factors present at the time of the procedure. This risk score may guide clinical decision-making and resource allocation for PCI patients at the time of hospital discharge.
OBJECTIVES: To develop a risk model that can be used to identify PCI patients at higher risk of readmission who may benefit from additional resources at the time of discharge. BACKGROUND: A high proportion of patients undergoing PCI are readmitted within 30 days of discharge. METHODS: The sample comprised patients aged ≥65 years who underwent PCI at a CathPCI Registry®-participating hospital and could be linked with 100% Medicare fee-for-service claims between 01/2007 and 12/2009. The sample (n = 388,078) was randomly divided into risk score development (n = 193,899) and validation (n = 194,179) cohorts. We did not count as readmissions those associated with staged revascularization procedures. Multivariable logistic regression models using stepwise selection models were estimated to identify variables independently associated with all-cause 30-day readmission. RESULTS: The mean 30-day readmission rates for the development (11.36%) and validation (11.35%) cohorts were similar. In total, 19 variables were significantly associated with risk of 30-day readmission (P < 0.05), and model c-statistics were similar in the development (0.67) and validation (0.66) cohorts. The simple risk score based on 14 variables identified patients at high and low risk of readmission. Patients with a score of ≥13 (15.4% of sample) had more than an 18.5% risk of readmission, while patients with a score ≤6 (41.9% of sample) had less than an 8% risk of readmission. CONCLUSION: Among PCI patients, risk of readmission can be estimated using clinical factors present at the time of the procedure. This risk score may guide clinical decision-making and resource allocation for PCI patients at the time of hospital discharge.
Authors: Edward L Hannan; Ye Zhong; Harlan Krumholz; Gary Walford; David R Holmes; Nicholas J Stamato; Alice K Jacobs; Ferdinand J Venditti; Samin Sharma; Spencer B King Journal: JACC Cardiovasc Interv Date: 2011-12 Impact factor: 11.195
Authors: Farhan J Khawaja; Nilay D Shah; Ryan J Lennon; Joshua P Slusser; Aziz A Alkatib; Charanjit S Rihal; Bernard J Gersh; Victor M Montori; David R Holmes; Malcolm R Bell; Jeptha P Curtis; Harlan M Krumholz; Henry H Ting Journal: Arch Intern Med Date: 2011-11-28
Authors: M Moscucci; E Kline-Rogers; D Share; M O'Donnell; A Maxwell-Eward; W L Meengs; P Kraft; A C DeFranco; J L Chambers; K Patel; J G McGinnity; K A Eagle Journal: Circulation Date: 2001-07-17 Impact factor: 29.690
Authors: G T O'Connor; D J Malenka; H Quinton; J F Robb; M A Kellett; S Shubrooks; W A Bradley; M J Hearne; M W Watkins; D E Wennberg; B Hettleman; D J O'Rourke; P D McGrath; T Ryan; P VerLee Journal: J Am Coll Cardiol Date: 1999-09 Impact factor: 24.094
Authors: Chi Hang Lee; Ron T van Domburg; Angela Hoye; Pedro A Lemos; Kengo Tanabe; Pieter C Smits; Willem J van der Giessen; Pim de Feyter; Patrick W Serruys Journal: J Invasive Cardiol Date: 2004-11 Impact factor: 2.022
Authors: Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz Journal: Circ Heart Fail Date: 2009-11-10 Impact factor: 8.790
Authors: Gregory J Dehmer; Douglas Weaver; Matthew T Roe; Sarah Milford-Beland; Susan Fitzgerald; Anthony Hermann; John Messenger; Issam Moussa; Kirk Garratt; John Rumsfeld; Ralph G Brindis Journal: J Am Coll Cardiol Date: 2012-10-17 Impact factor: 24.094
Authors: Junjie Zhang; Qingning Su; William G Loudon; Katherine L Lee; Jane Luo; Brent A Dethlefs; Shengwen Calvin Li Journal: J Funct Morphol Kinesiol Date: 2019-12-03
Authors: Mahesh K Vidula; Cian P McCarthy; Neel M Butala; Kevin F Kennedy; Jason H Wasfy; Robert W Yeh; Eric A Secemsky Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240